Convatec Group PLC (LON:CTEC)
256.00
+4.20 (1.67%)
At close: Feb 26, 2026
Convatec Group Revenue
In the year 2025, Convatec Group had annual revenue of $2.44B USD with 6.54% growth. Convatec Group had revenue of $1.26B in the half year ending December 31, 2025, with 15.84% growth.
Revenue
$2.44B
Revenue Growth
+6.54%
P/S Ratio
2.71
Revenue / Employee
$243.90K
Employees
10,000
Market Cap
4.91B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.44B | 149.80M | 6.54% |
| Dec 31, 2024 | 2.29B | 146.80M | 6.85% |
| Dec 31, 2023 | 2.14B | 69.90M | 3.37% |
| Dec 31, 2022 | 2.07B | 34.20M | 1.68% |
| Dec 31, 2021 | 2.04B | 144.00M | 7.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Spire Healthcare Group | 1.55B |
| CVS Group | 673.20M |
| Genus | 672.80M |
Convatec Group News
- 2 days ago - Convatec Group PLC (CNVVY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Convatec stars as FTSE 100 closes with little change - Evening Standard
- 2 days ago - ConvaTec Leads FTSE 100 Gainers on Higher Revenue, Raised Outlook - The Wall Street Journal
- 2 days ago - Convatec Group PLC 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 2 days ago - ConvaTec Group FY25 Profit Down, Lifts Dividend; Backs FY26 View, Lifts FY27 Outlook - Nasdaq
- 5 days ago - WIT Partners Advisory Pte. Ltd. Buys 1,720 Shares of Exxon Mobil Corp (XOM) - GuruFocus
- 9 days ago - Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks - Benzinga
- 10 days ago - Invesco International Growth Fund Q4 2025 Portfolio Update - Seeking Alpha